Evid Invest
Holders — by stockHoldings — by fund

Knott David M Jr

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001892770

$182.8M

disclosed book value

80

positions

17%

largest position share

Positions, as of 2026-09-30

top 80 of 80 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1GOOGAlphabet Inc-Cl C91,420$31.2M17%
2APOApollo Global Management, Inc.225,000$26.1M14.3%
3IOVAIovance Biotherapeutics, Inc.1.2M$17.3M9.4%
4XERSXeris Biopharma Holdings, Inc.1.0M$9.6M5.2%
5SNDXSyndax Pharmaceutical, Inc.428,294$8.1M4.4%
6TVTXTravere Therapeutics, Inc.129,967$7.7M4.2%
7BBIOBridgebio Pharma, Inc.100,000$6.6M3.6%
8JPMJPMorgan Chase & Co.17,409$5.8M3.2%
9LPL Financial Holdings Inc.16,500$5.0M2.8%
10JAAAJanus Henderson AAA CLO ETF93,528$4.7M2.6%
11ALKSAlkermes PLC114,459$4.6M2.5%
12PTGXProtagonist Therapeutics, Inc32,723$4.6M2.5%
13HELPCybin Inc370,000$4.5M2.5%
14COGTCogent Biosciences Inc.136,081$4.4M2.4%
15VRDNViridian Therapeutics, Inc.191,000$3.9M2.2%
16TGTXTG Therapeutics, Inc.59,839$3.3M1.8%
17RCUSArcus Biosciences, Inc.100,241$2.6M1.4%
18MDGLMadrigal Pharmaaceuticals, Inc.3,600$1.8M1%
19RLMDRelmada Therapeutics, Inc.480,000$1.8M1%
20XBISPDR S&P Biotech ETF11,000$1.7M0.9%
21ABAllianceBernstein Holding L.P.48,000$1.7M0.9%
22AGIOAgios Pharmaceutical, Inc.49,058$1.6M0.9%
23OBIOOrchestra Biomed Holdings, Inc.253,651$1.6M0.9%
24CGEMCullinan Therapeutics, Inc.95,369$1.5M0.8%
25CDNACareDx, Inc.22,165$1.4M0.8%
26ELVNEnliven Therapeutics, Inc.28,904$1.3M0.7%
27SPRBSpruce Biosciences, Inc.26,085$1.3M0.7%
28CLOZEldgridge BBB-B47,807$1.3M0.7%
29DCGODocGo, Inc.2.7M$1.1M0.6%
30PFEPfizer Inc.32,337$922,2510.5%
31ORKAOruka Therapeutics, Inc.11,000$916,1900.5%
32COLLCollegium Pharmaceutical, Inc.39,000$850,9800.5%
33DYNDyne Therapeutics, Inc.52,000$837,7200.5%
34AAPLApple Inc.2,494$830,5520.5%
35MSFTMicrosoft Corporation1,600$820,6400.4%
36JNJJohnson & Johnson2,922$773,5700.4%
37RZLTRezolute, Inc.159,638$660,9010.4%
38CNQCanadian Natural Resources Limited13,918$655,1200.4%
39LBRXLB Pharmaceuticals, Inc.17,065$654,9550.4%
40IBBiShares Biotechnology ETF2,500$526,3250.3%
41SLDBSolid Bioscience Inc.71,129$514,2630.3%
42DWDPEURDuPont de Nemours, Inc.3,767$489,2960.3%
43IBMInternational Business Machines2,142$471,0900.3%
44CNTBConnect Biopharma Holdings Limited419,866$461,8530.3%
45BIIBBiogen Inc.2,000$451,7600.2%
46EWTXEdgewise Therapeutics, Inc.10,502$426,3810.2%
47PTHSPelthos Therapeutics, Inc.17,644$370,7000.2%
48NVDANvidia Corp1,280$292,3260.2%
49RHPRyman Hospitality Properties, Inc.2,400$286,8720.2%
50INSMInsmed Incorporated2,253$257,1570.1%
51MLYSMineralys Therapeutics, Inc.10,000$251,3000.1%
52AVGOBroadcom, Inc.710$249,3450.1%
53KMBKimberly-Clark Corporation2,400$233,8320.1%
54MDLZMondelez International Inc.3,000$173,4600.1%
55NVCTNuvectis Pharma, Inc.6,777$143,1300.1%
56LEGHLegacy Housing Corporation4,000$114,6800.1%
57PWRQuanta Services, Inc.176$113,0820.1%
58EBCEastern Bankshares Inc5,000$104,6500.1%
59GOOGLAlphabet Inc CL A300$103,2240.1%
60ABVXAbivax1,000$99,0200.1%
61IWPiShares Russell Mid-Cap Growth695$95,6880.1%
62CTVACorteva, Inc.1,206$93,6460.1%
63IVVDInvivyd, Inc.100,000$87,0100%
64RAINRain Enhancement Technologies Holdco Inc101,686$81,3490%
65URIUnited Rentals, Inc.78$78,0610%
66AMZNAmazon.com Inc.300$74,7450%
67DHRDanaher Corporation180$39,8790%
68DOWDow Inc.1,206$33,2130%
69FSKFS KKR Capital Corp.2,875$31,5960%
70TMOThermo Fisher Scientific, Inc.45$30,3770%
71OXYOccidental Petroleum Corporation469$25,9450%
72BRSLBrightstar Lottery PLC2,500$24,9750%
73BXBlackstone Group LP210$23,5390%
74UNHUnitedHealth Group57$20,9240%
75CRMSalesforce, Inc.77$17,6770%
76STWDStarwood Property Trust, Inc.400$5,4000%
77KDKyndryl Holdings Inc.428$4,8190%
78OXY/WSOccidential Pertro Wts exp. 8/3/27194$4,2680%
79GEHCGE HealthCare Technologies Inc50$3,2680%
80WABWabtec Corporation6$1,7230%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.